American Heart Journal
Volume 158, Issue 4 , Pages 622-628 , October 2009

Electrocardiographic predictors of atrial fibrillation

  • Marco V. Perez, MD

      Affiliations

    • Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA
    • Corresponding Author InformationReprint requests: Marco V. Perez, MD, Falk CVRC, 300 Pasteur Drive, Stanford, CA 94305-5406.
    • ,
  • Frederick E. Dewey, MD

      Affiliations

    • Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA
    • ,
  • Rachel Marcus, MD

      Affiliations

    • Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA
    • ,
  • Euan A. Ashley, MRCP, DPhil, MD

      Affiliations

    • Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA
    • ,
  • Amin A. Al-Ahmad, MD

      Affiliations

    • Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA
    • ,
  • Paul J. Wang, MD

      Affiliations

    • Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA
    • ,
  • Victor F. Froelicher, MD, FACC

      Affiliations

    • Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA
    • Cardiovascular Medicine, Palo Alto Veterans Affairs Health Care System, Stanford, CA

Received 26 May 2009 ,Accepted 6 August 2009.

References 

  1. Feinberg WM, Blackshear JL, Laupacis A, et al. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 1995;155:469–473
  2. Wolf PA, Mitchell JB, Baker CS, et al. Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 1998;158:229–234
  3. Benjamin EJ, Wolf PA, D'Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation. 1998;98:946–952
  4. Staszewski J. Atrial fibrillation characteristics in patients with ischaemic stroke. Kardiol Pol. 2007;65:751–757
  5. Michelson EL, Morganroth J, MacVaugh H. Postoperative arrhythmias after coronary artery and cardiac valvular surgery detected by long-term electrocardiographic monitoring. Am Heart J. 1979;97:442–448
  6. Crosby LH, Pifalo WB, Woll KR, et al. Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol. 1990;66:1520–1522
  7. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996;94:390–397
  8. Daoud EG, Strickberger SA, Man KC, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med. 1997;337:1785–1791
  9. Giri S, White CM, Dunn AB, et al. Oral amiodarone for prevention of atrial fibrillation after open heart surgery, the Atrial Fibrillation Suppression Trial (AFIST): a randomised placebo-controlled trial. Lancet. 2001;357:830–836
  10. Halonen J, Halonen P, Jarvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. Jama. 2007;297:1562–1567
  11. Patti G, Chello M, Candura D, et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation. 2006;114:1455–1461
  12. Cui Q, Zhang W, Wang H, et al. Left and right atrial size and the occurrence predictors in patients with paroxysmal atrial fibrillation. Int J Cardiol. 2007;
  13. Tanabe K, Yamaguchi K, Tani T, et al. Left atrial volume: predictor of atrial fibrillation in patients with degenerative mitral regurgitation. J Heart Valve Dis. 2007;16:8–12
  14. Bollmann A, Husser D, Steinert R, et al. Echocardiographic and electrocardiographic predictors for atrial fibrillation recurrence following cardioversion. J Cardiovasc Electrophysiol. 2003;14(10 Suppl):S162–S165
  15. Varounis C, Dagres N, Maounis T, et al. Atrial premature complexes and heart rate have prognostic significance in 1-month atrial fibrillation recurrence after electrical cardioversion. Europace. 2007;9:633–637
  16. Thong T, McNames J, Aboy M, et al. Prediction of paroxysmal atrial fibrillation by analysis of atrial premature complexes. IEEE Trans Biomed Eng. 2004;51:561–569
  17. Steinberg JS, Zelenkofske S, Wong SC, et al. Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery. Circulation. 1993;88:2618–2622
  18. Hayashida N, Shojima T, Yokokura Y, et al. P-wave signal-averaged electrocardiogram for predicting atrial arrhythmia after cardiac surgery. Ann Thorac Surg. 2005;79:859–864
  19. Koide Y, Yotsukura M, Sakata K, et al. Investigation of the predictors of transition to persistent atrial fibrillation in patients with paroxysmal atrial fibrillation. Clin Cardiol. 2002;25:69–75
  20. Abe Y, Fukunami M, Yamada T, et al. Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation by signal-averaged electrocardiography: a prospective study. Circulation. 1997;96:2612–2616
  21. Cecchi F, Montereggi A, Olivotto I, et al. Risk for atrial fibrillation in patients with hypertrophic cardiomyopathy assessed by signal averaged P wave duration. Heart. 1997;78:44–49
  22. Montereggi A, Marconi P, Olivotto I, et al. Signal-averaged P-wave duration and risk of paroxysmal atrial fibrillation in hyperthyroidism. Am J Cardiol. 1996;77:266–269
  23. Piechowiak M, Banach M, Ruta J, et al. Risk factors for atrial fibrillation in adult patients in long-term observation following surgical closure of atrial septal defect type II. Thorac Cardiovasc Surg. 2006;54:259–263
  24. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol. 2000;23:352–358
  25. Boriani G, Diemberger I, Biffi M, et al. P wave dispersion and short-term vs. late atrial fibrillation recurrences after cardioversion. Int J Cardiol. 2005;101:355–361
  26. Amasyali B, Kose S, Aytemir K, et al. P wave dispersion predicts recurrence of paroxysmal atrial fibrillation in patients with atrioventricular nodal reentrant tachycardia treated with radiofrequency catheter ablation. Ann Noninvasive Electrocardiol. 2006;11:263–270
  27. Aytemir K, Amasyali B, Kose S, et al. Maximum P-wave duration and P-wave dispersion predict recurrence of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome after successful radiofrequency catheter ablation. J Interv Card Electrophysiol. 2004;11:21–27
  28. De Bacquer D, Willekens J, De Backer G. Long-term prognostic value of p-wave characteristics for the development of atrial fibrillation in subjects aged 55 to 74 years at baseline. Am J Cardiol. 2007;100:850–854
  29. Romhilt DW, Estes EH. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J. 1968;75:752–758
  30. Ball MF, Pipberger HV. The normal spatial QRS-T angle of the orthogonal vectorcardiogram. Am Heart J. 1958;56:611–615
  31. Rautaharju PM, Warren JW, Jain U, et al. Cardiac Infarction Injury Score: an electrocardiographic coding scheme for ischemic heart disease. Circulation. 1981;64:249–256
  32. Palmeri ST, Harrison DG, Cobb FR, et al. A QRS scoring system for assessing left ventricular function after myocardial infarction. N Engl J Med. 1982;306:4–9
  33. Perez MV, Dewey FE, Tan SY, et al. Added value of a resting ECG neural network that predicts cardiovascular mortality. Ann Noninvasive Electrocardiol. 2009;14:26–34
  34. Braunwald E. Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med. 1997;337:1360–1369
  35. Wachtell K, Lehto M, Gerdts E, et al. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. J Am Coll Cardiol. 2005;45:712–719
  36. Okin PM, Wachtell K, Devereux RB, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. Jama. 2006;296:1242–1248

PII: S0002-8703(09)00612-7

doi: 10.1016/j.ahj.2009.08.002

American Heart Journal
Volume 158, Issue 4 , Pages 622-628 , October 2009

Article Tools

* Image Usage & Resolution